SOMERSET, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- inVentiv Clinical Solutions, LLC (inVentiv Clinical), a division of inVentiv Health (Nasdaq:VTIV), today announced the formation of the inVentiv Clinical Global Alliance, a network of leading clinical research partners in strategic locations throughout the world. In conjunction, inVentiv Clinical announced the first member of the Global Alliance will be ActivaCro, a regional full-service Contract Research Organization (CRO) based in Argentina, with operations in Chile, Uruguay and Mexico.
"Our clients are increasingly interested in managing clinical trials on a global basis. As such, we are strategically expanding our footprint by creating alliances with trusted, well-reputed CROs in key markets throughout the world," said Mike Hlinak, President and CEO of inVentiv Clinical Solutions. "ActivaCro has built an exceptional reputation for providing high quality clinical research services in Latin America. Coupled with our existing operation in Brazil, this arrangement will provide expansive access to Latin American patient populations. We look forward to tapping their strong local knowledge to deliver superior service and efficiency for our clients."
"inVentiv Clinical is a leader in the growing field of clinical outsourcing, and is widely recognized for its impressive range of flexible solutions," said Mario Boskis, Director of ActivaCro. "We look forward to partnering with them and expanding our business in Latin America by leveraging their existing client base."
The inVentiv Clinical Global Alliance will enable inVentiv Clinical to expand its services globally, while providing clients with broader patient access and enhanced efficiencies. All qualifying members will pass inVentiv's quality reviews and agree to confidential terms related to joint marketing plans, equity interests or other provisions designed to assure a long term, collaborative approach to global clinical trials. The Global Alliance will complement inVentiv Clinical's fully-owned operations in India, Brazil, Spain, Taiwan and the U.S.
About ActivaCro
ActivaCro is a regional full-service Contract Research Organization (CRO) based in Buenos Aires, Argentina, with operations in South America and Mexico that assists the biotechnology, pharmaceutical and medical device industries in every stage of preclinical (safety and efficacy studies), clinical development (Phase I-IV Clinical Trials) and registration process. ActivaCro offers a broad spectrum of services in the field of clinical research, ranging from the design of study documents, subject recruitment, project management, and statistics and medical writing. For more information, visit www.activa-cro.com
About inVentiv Clinical Solutions
inVentiv Clinical Solutions is the premier provider of unique clinical outsourcing solutions, allowing the greatest control and flexibility through unmatched access to high quality clinical resources. As a strategic partner, inVentiv Clinical Solutions provides clinical trial management and monitoring, data management and biostatistics solutions, medical writing, regulatory consulting and liaison services and patient and investigator recruitment. These services are complemented by traditional clinical staffing capabilities through our industry leading staffing divisions, MedFocus and Smith Hanley Consulting Group. For more information, visit www.inventivclinical.com.
About inVentiv Health
inVentiv Health (Nasdaq:VTIV) is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including the top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.